California State Teachers Retirement System Boosts Stock Position in Bruker Corporation $BRKR

Key Points

• CalSTRS increased its Bruker stake by 21.3% in the first quarter, owning 122,579 shares valued at approximately $4.43 million. Institutional investors collectively hold 79.52% of BRKR.
• Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average price target of $56.64, although targets range from $53 to $70.
• Bruker reported quarterly EPS of $0.49, beating estimates of $0.38, while revenue rose 5.2% year over year to $838.5 million. The company reaffirmed fiscal 2026 EPS guidance of $2.10–$2.15 and paid a $0.05 quarterly dividend.

California State Teachers Retirement System lifted its holdings in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 21.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 122,579 shares of the medical research company's stock after buying an additional 21,552 shares during the quarter. California State Teachers Retirement System owned approximately 0.08% of Bruker worth $4,428,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in BRKR. Orbis Allan Gray Ltd raised its holdings in shares of Bruker by 5.4% during the fourth quarter. Orbis Allan Gray Ltd now owns 14,906,730 shares of the medical research company's stock valued at $702,256,000 after acquiring an additional 761,258 shares during the last quarter. State Street Corp raised its holdings in Bruker by 2.5% in the 4th quarter. State Street Corp now owns 3,831,814 shares of the medical research company's stock valued at $180,700,000 after acquiring an additional 91,706 shares during the last quarter. AQR Capital Management LLC lifted its stake in Bruker by 125.3% in the 2nd quarter. AQR Capital Management LLC now owns 3,326,820 shares of the medical research company's stock worth $137,065,000 after purchasing an additional 1,850,215 shares in the last quarter. Sculptor Capital LP lifted its stake in Bruker by 9.0% in the 1st quarter. Sculptor Capital LP now owns 3,270,000 shares of the medical research company's stock worth $118,112,000 after purchasing an additional 270,000 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Bruker by 2,963.4% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,366,520 shares of the medical research company's stock valued at $111,488,000 after purchasing an additional 2,289,269 shares in the last quarter. 79.52% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on BRKR. JPMorgan Chase & Co. upped their target price on Bruker from $55.00 to $65.00 and gave the company an "overweight" rating in a report on Monday, June 8th. Guggenheim raised their price target on shares of Bruker from $50.00 to $70.00 and gave the stock a "buy" rating in a report on Monday, June 29th. Citigroup decreased their price objective on Bruker from $60.00 to $53.00 and set a "hold" rating on the stock in a report on Wednesday. Wall Street Zen upgraded shares of Bruker from a "hold" rating to a "buy" rating in a research report on Saturday, May 9th. Finally, Wolfe Research started coverage on shares of Bruker in a report on Monday, June 1st. They issued a "peer perform" rating for the company. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating, four have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $56.64.

Bruker Trading Up 4.2%

Shares of NASDAQ:BRKR opened at $53.41 on Friday. The company has a market cap of $8.13 billion, a PE ratio of -76.30, a P/E/G ratio of 1.57 and a beta of 1.28. The company has a current ratio of 1.85, a quick ratio of 0.72 and a debt-to-equity ratio of 0.76. The company's 50 day moving average is $58.50 and its two-hundred day moving average is $46.80. Bruker Corporation has a 52 week low of $28.53 and a 52 week high of $65.30.

Bruker (NASDAQ:BRKR - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The medical research company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.11. The business had revenue of $838.50 million during the quarter, compared to analysts' expectations of $853.57 million. Bruker had a positive return on equity of 12.47% and a negative net margin of 2.35%.The business's quarterly revenue was up 5.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.32 EPS. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Equities analysts predict that Bruker Corporation will post 2.12 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, July 7th. Stockholders of record on Monday, June 22nd were given a dividend of $0.05 per share. The ex-dividend date was Monday, June 22nd. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. Bruker's payout ratio is -28.57%.

About Bruker

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker's product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corporation (NASDAQ:BRKR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source